Is EUCR or JNJ a better dividend investment in 2026?

EUCR currently yields 19.92% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: EUCR offers higher current income.

What is the dividend yield difference between EUCR and JNJ?

EUCR has a forward dividend yield of 19.92% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 16.56 percentage points.

Home › Compare › EUCR vs JNJ

EUCR vs JNJ: Dividend Comparison 2026

EUCR yields 19.92% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EUCR wins by $52.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

EUCR

● Live price

19.92%

Share price

$10.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$72.7K

Annual income

$6,681.84

Full EUCR calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — EUCR vs JNJ

📍 EUCR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EUCR	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EUCR + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EUCR pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EUCR

Annual income on $10K today (after 15% tax)

$1,693.23/yr

After 10yr DRIP, annual income (after tax)

$5,679.56/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, EUCR beats the other by $4,975.95/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EUCR + JNJ for your $10,000?

EUCR: 50%JNJ: 50%

100% JNJ50/50100% EUCR

Portfolio after 10yr

$46.3K

Annual income

$3,754.81/yr

Blended yield

8.10%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EUCR

No analyst data

Altman Z

5.8

Piotroski

4/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EUCR buys

JNJ buys

No recent congressional trades found for EUCR or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEUCRJNJ

Forward yield	19.92% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$72.7K ✓	$20.0K
Annual income after 10y	$6,681.84 ✓	$827.78
Total dividends collected	$41.2K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: EUCR vs JNJ ($10,000, DRIP)

Year	EUCR Portfolio	EUCR Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,692	$1,992.03	$10,676	$355.77	+$2.0K → EUCR
2	$15,943	$2,362.89	$11,407	$389.39	+$4.5K → EUCR
3	$19,833	$2,774.01	$12,198	$426.53	+$7.6K → EUCR
4	$24,447	$3,225.09	$13,056	$467.62	+$11.4K → EUCR
5	$29,873	$3,715.22	$13,987	$513.12	+$15.9K → EUCR
6	$36,207	$4,242.88	$14,998	$563.56	+$21.2K → EUCR
7	$43,548	$4,806.07	$16,098	$619.52	+$27.4K → EUCR
8	$51,999	$5,402.29	$17,295	$681.69	+$34.7K → EUCR
9	$61,667	$6,028.62	$18,599	$750.82	+$43.1K → EUCR
10	$72,666	$6,681.84	$20,022	$827.78	+$52.6K → EUCR

EUCR vs JNJ: Complete Analysis 2026

EUCR — Stock

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Full EUCR Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this EUCR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EUCR vs SCHD EUCR vs JEPI EUCR vs O EUCR vs KO EUCR vs MAIN EUCR vs ABBV EUCR vs MRK EUCR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.